Connect with us

Technology

Withings Introduces StethO Sense, Bringing Heart and Lung Sound Analysis to BeamO

Published

13 hours ago

on

StethO Sense, a new Withings+ service powered by eMurmur® and StethoMe, brings on-demand AI-powered heart sound analysis and breathing pattern insights to BeamO users, allowing families to track changes in heart sounds and breathing patterns early from home.

ISSY-LES-MOULINEAUX, France, Sept. 4, 2026 /PRNewswire/ — Withings today announced StethO Sense, a new service within Withings+, the premium membership tier of the Withings app, that gives parents a closer listen to what their child’s bodies are already saying. It brings on-demand AI-powered analysis of heart and lung recordings to BeamO, the company’s compact, FDA-cleared health device that combines a clinical-grade thermometer, 1-lead ECG, and digital stethoscope in one tool.

Powered by eMurmur Heart AI for abnormal murmur detection, and StethoMe for breathing sound insights, StethO Sense provides BeamO users with the ability to analyze heart and lung recordings from the comfort of the home. Withings+ members can access unlimited analyses at home, with results available in seconds. StethO Sense results are not a diagnosis and are intended to be shared with a healthcare professional.1

“Hearts don’t always tell us when something is wrong. A heart murmur, an unusual sound caused by blood flowing through the heart, can go unnoticed for years. StethO Sense lets families record heart sounds at home, in seconds, as often as they want, and build a record they can bring to their doctor. It doesn’t replace a visit; rather, StethO Sense gives you additional health data to bring to one,” said Livia Robic, Product Manager, BeamO.

How StethO Sense Works
From the StethO Sense section of the Withings+ app, users can select a heart or lung recording and instantly start the analysis. Heart recordings are taken at one of four standard positions, while lung recordings are taken at up to eight positions at 12 years of age and above, and six positions for those below 12 years of age. BeamO guides users through the process with an anatomical diagram. Results are delivered within seconds in the Withings app.1,1b

StethO Sense complements the Withings+ Cardio Check-Up service, which provides a cardiologist review of a user’s ECG within 24 hours, up to four times a year. The two services are complementary: Cardio Check-Up provides a cardiologist’s review of an ECG, while StethO Sense provides unlimited AI-assisted analysis of heart and lung recordings that users can share with a healthcare professional.1

Designed for Families and Everyday Health Monitoring
StethO Sense is designed to provide peace of mind to people who want additional insight into the health signals they can capture at home, including:

For children & families:

Identify changes in breathing sounds: StethoMe’s Breathing Index gives a score, 0–100, based on their breathing sounds, breathing quality, breathing rate, plus respiratory rhythm, and heart rate, helping families notice changes over time. It is designed to give insight into day-to-day breathing patterns and if necessary to be shared directly with a healthcare professional, with a report exportable from the Withings+ app.Track heart murmurs: StethO Sense lets parents record their child’s heart sounds at home, tracking heart murmurs and changes in heart sounds. It is designed to be shared directly with a healthcare professional and a report is exportable from the Withings+ app.Spot early symptoms before an urgent care visit: StethO Sense also tracks changes in heart which is particularly important during winter months.

Adults monitoring their heart health:

Track heart murmurs: Heart murmurs are relatively common, affecting nearly one in four adults.6 While many are harmless, murmurs can sometimes be an early sign of valvular heart disease, a condition that often develops silently and is easy to miss without a regular check. A 2024 study of over 4,200 older adults found that more than a quarter had valvular heart disease that had never been diagnosed.7 StethO Sense gives users a way to record and track heart sounds over time, rather than only at an annual check-up, and to share those recordings with a healthcare professional.Athletes: StethO Sense is valuable for athletes as heart murmur checks are increasingly part of routine sports physicals, particularly in the US, where screening for conditions like hypertrophic cardiomyopathy (HCM),8 a leading cause of sudden cardiac events in young athletes, is a growing focus.

eMurmur: Heart Sound Analysis
StethO Sense’s heart sounds analysis is provided by eMurmur2, a medical AI company that built an open intelligence layer to power auscultation hardware and software. eMurmur Heart AI analyzes BeamO heart sound recordings in seconds, and distinguishes between the absence of a murmur, innocent murmurs and abnormal murmurs. Across multiple blinded prospective clinical studies, eMurmur Heart AI demonstrated approximately 90% sensitivity and specificity for pathologic murmur detection.3 It also provides the heart rate and a confidence score for its findings. eMurmur Heart AI is FDA-cleared for use on both children and adults.4

StethoMe: Breathing Sound Insights
StethO Sense also brings a new Breathing Index from StethoMe,5a an AI company specializing in pulmonary sound analysis. The Breathing Index provides a score 0–100 based on breathing sounds and quality of breathing. It is designed to help people notice changes in their breathing patterns over time, with a guided protocol that adapts to age (six recording points for children, eight for adults). In the US, StethoMe’s Breathing Index is offered as a general wellness feature.5b

Extending StethO Sense to Healthcare Professionals
StethO Sense also extends to BeamO PrO, the professional version of the device used by clinicians and care teams. With eMurmur’s FDA-cleared Heart AI, healthcare professionals can perform heart sound assessments efficiently across a range of care settings, including nursing homes. AI-assisted auscultation has also been shown to reduce inappropriate cardiology referrals by up to 50–75%,3 helping care teams prioritize the patients who need further investigation. The technology is designed to support clinical workflows by providing additional information that can be considered alongside a healthcare professional’s assessment.

Availability
StethO Sense will be available beginning October 1, 2026, exclusively for Withings+ users. To celebrate the launch, existing BeamO users who purchased their device before October 1, 2026 will receive a complimentary one-month trial of Withings+. Consumers purchasing BeamO for $249.95 starting October 1, 2026 will get a 1-month free trial of Withings+ to experience StethO Sense.

Learn more about StethO Sense and BeamO at withings.com/beam-o or visit the Withings booth at IFA: Beauty Hub, Booth H13-107, from September 4–8, 2026, in Berlin, Germany.

Notes to Editors

About BeamO
BeamO is Withings’ health thermometer, combining a clinical-grade thermometer, 1-lead electrocardiogram, and digital stethoscope in a single compact FDA-cleared device. Designed for the whole family, BeamO lets anyone check their temperature, and heart and lung sounds in a minute, then seamlessly share the results with a doctor. BeamO is intended to complement, not replace, an in-person medical exam. Learn more at withings.com.

About Withings+
Every BeamO comes with a complimentary one-month trial of Withings+,9 automatically activated at setup. Withings+ unlocks the complete suite of advanced health scores and personalized AI-driven feedback for $9.95 / €9.95 / £8.95 per month, or $99.50 / €99.50 / £89.50 per year.

Advanced Health Services: get unlimited, on-demand StethO Sense analysis for heart murmurs and breathing pattern insights, plus a cardiologist-reviewed ECG via the Cardio Check-Up service

AI Health Assistant: an on-demand coach that answers health questions, helps you interpret latest results, and recommends actionable next steps

Withings Intelligence: proactively analyzes how data evolves over time, flags negative trends, and shows how overall habits and changes shape long-term health

Lifetime Guarantee: device protection for as long as you use it, reflecting Withings’ commitment to long-term health partnership

About the Partners Powering StethO Sense
eMurmur: a medical AI company offering an open intelligence layer to power auscultation hardware and software. eMurmur also offers a separate lung sound AI, which is not part of the StethO Sense integration.

StethoMe: an AI company specializing in pulmonary sound analysis. In the United States, the StethoMe Breathing Index is offered as a general wellness feature and is not FDA-cleared.

About Withings
A pioneer in real-life health monitoring, Withings created the first connected scale in 2009 and has continually innovated since then to offer an ecosystem of clinically validated connected devices, used by 12 million people worldwide, as well as by numerous renowned healthcare centers and research institutes. Withings collaborates with leading research institutions including Stanford and Harvard. Its ecosystem spans hybrid smartwatches and blood pressure monitors that help people track their health and act early. Available at withings.com.

Media Contact
Alex McKechnie
alex.mckechnie@12080group.com
475.399.4056

References & Disclaimers

1AI results are diagnosis-assisting only. Final clinical assessment must be performed by a qualified healthcare provider.

1bStethO Sense is a service that combines BeamO recordings with third-party analysis software.

2eMurmur is a trademark of CSD Labs GmbH, a healthcare technology company specializing in AI-powered digital auscultation and cardiac sound analysis. eMurmur Heart AI is developed and maintained by CSD Labs and is integrated into StethO Sense for heart sound analysis only. Its algorithm has been validated in peer-reviewed clinical studies across pediatric and adult populations. For more information, visit www.emurmur.com.

3Thompson WR et al. Pediatric Cardiology. 2019;40(3):623–629. doi:10.1007/s00246-018-2036-z. Study of 603 patients; sensitivity 93% (CI 90–95%), specificity 81% (CI 75–85%). FDA 510(k): K181988 (eMurmur ID, 2019); K220766 (eMurmur Heart AI, 2022).

4In the United States, eMurmur’s algorithm is FDA-cleared for use on both adults and children. eMurmur results are diagnosis-assisting only for healthcare professional use. Final clinical assessment must be performed by a qualified healthcare provider.

5aStethoMe is a general wellness product in the US. It is not FDA-cleared and is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider with any health concerns. Its AI algorithms analyze respiratory sound patterns and are the result of 8+ years of research with academic partners including Poznan University of Medical Sciences. For more information, visit www.stethome.com.

5bStethoMe’s Breathing Index is a wellness feature intended for general respiratory sound tracking. It is not intended for use by individuals with diagnosed respiratory conditions (including but not limited to asthma, COPD, bronchitis, bronchiolitis, etc…) or as a substitute for medical advice, diagnosis, or treatment.

6Heggdal M, et al. Heart murmurs in the general population: diagnostic value and prevalence from the Tromsø Study. 2025.

7Tsampasian V, Militaru C, Pareek N, et al. Prevalence of asymptomatic valvular heart disease in the elderly population: a community-based echocardiographic study. European Heart Journal – Cardiovascular Imaging, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11288748/

8American Heart Association. “HCM in Young Adults and Student Athletes.” Accessed August 26, 2026. https://www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults/hcm-in-young-adults-and-student-athletes

9Subject to Withings terms and conditions, available at: https://www.withings.com/us/en/legal/services-terms-and-conditions

View original content to download multimedia:https://www.prnewswire.com/news-releases/withings-introduces-stetho-sense-bringing-heart-and-lung-sound-analysis-to-beamo-302869284.html

SOURCE Withings

Related Topics:
Continue Reading

Technology

Rho Launches Card Payments on Invoices, Letting Businesses Accept Credit Card, Debit Card, and Google Pay

Published

1 hour ago

on

September 4, 2026

By

Rho Invoicing customers can now accept credit card payments on invoices alongside ACH and wire, from the same account they already use for banking, with invoices syncing automatically to QuickBooks Online

NEW YORK, Sept. 4, 2026 /PRNewswire/ — Rho, the all-in-one finance platform for businesses, today announced that Rho Invoicing customers can now accept credit and debit card payments, including Google Pay, directly on their invoices. The feature is rolling out to eligible Rho Invoicing customers and adds to the existing ACH, domestic wire, and international wire options already available on Rho invoices. No separate merchant account, no new dashboard, and no waiting on a wire.

Here is how it works for the payer: your client opens the invoice, enters their card information, and pays in a few clicks. Card payments carry a processing fee of 2.9% plus $0.30 per transaction, paid by the business issuing the invoice and deducted from the payment before depositing into your account. Inbound ACH and wire stay free, and the payer never sees a surcharge at checkout. Card payments cover USD-denominated invoices and have a default daily limit of $10,000 across all of a business’s invoices, which can be raised on request.

An invoice is marked paid once the payout is initiated, and funds follow on card-network timelines rather than instantly. A business’s first card payment can take up to two weeks to deposit while Stripe, which powers Rho’s card payment features, completes its initial review.

Rho Invoicing remains free for all Rho customers, aside from card processing fees, and supports up to 100 line items per invoice with per-line sales tax, recurring billing, payment matching, and a fully white-labeled template that carries the business’s brand rather than Rho’s, with virtual account numbers that keep the business’s actual bank details private. Rho invoices sync into QuickBooks Online as accounts receivable through Rho’s direct integration, so AR aging stays accurate without duplicate entry.

Card payments run through the same Rho account a business already uses for banking, corporate cards, and bill pay. No merchant account. No second dashboard. No new password to add to a growing list. Getting paid should not add another tool to the financial stack.

Availability is limited to eligible Rho Invoicing customers for USD-denominated invoices. Access to and enablement of card payment functionality requires completion of Stripe’s verification process and is subject to third-party underwriting and approval, which is not guaranteed.

To learn more, read how to accept credit card payments with Rho Invoicing.

About Rho

Rho is the modern banking platform built for the AI era. Startups and growth-stage companies can open accounts in minutes, issue cards, manage expenses, pay bills, and close the books – all in one connected platform backed by real human support.

Rho is a fintech company, not a bank or an FDIC-insured depository institution. Checking account and card services provided by Webster Bank, a division of Santander Bank, N.A. Member FDIC.

Card payment features on Rho Invoicing, including credit card, debit card, and Google Pay options, are powered by Stripe, Inc. This content is for informational purposes only. It doesn’t necessarily reflect the views of Rho and should not be construed as legal, tax, benefits, financial, accounting, or other advice. If you need specific advice for your business, please consult with an expert, as rules and regulations change regularly.

Media Contact:
Justin Wolz
justin.wolz@rho.co
(919) 306-7084

View original content:https://www.prnewswire.com/news-releases/rho-launches-card-payments-on-invoices-letting-businesses-accept-credit-card-debit-card-and-google-pay-302870490.html

SOURCE Rho

Continue Reading

Technology

Amwell Receives Frost & Sullivan’s 2026 United States Technology Innovation Leadership Recognition for Technology-Enabled Care Platforms

Published

1 hour ago

on

September 4, 2026

By

Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical integration, and intelligent orchestration to improve access, efficiency, and outcomes.

SAN ANTONIO, Sept. 4, 2026 /CNW/ — As healthcare organizations move beyond fragmented telehealth solutions toward connected virtual care models, Amwell is helping redefine how digital care is delivered at scale. Frost & Sullivan is pleased to recognize Amwell with the 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms industry for its ability to address healthcare fragmentation through a unified platform that connects patients, health plan members, clinicians, and partner ecosystems across the care continuum.

Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Amwell excelled in both, demonstrating its ability to align strategic initiatives with evolving healthcare needs while executing with flexibility, scalability, and measurable customer impact. “The combination of reliability, flexibility, and clinically integrated workflows positions the Amwell Platform as a strategic enabler for organizations seeking to reduce fragmentation, improve member engagement with covered programs, expand access to care, and create more connected healthcare experiences,” said Sagar Mukhekar, Industry Analyst, Frost & Sullivan.

Guided by a strategy centered on connected care, interoperability, and continuous, digital innovation, Amwell has positioned the Amwell Platform as an operating layer for next-generation healthcare delivery. Rather than relying on disconnected point solutions, the platform integrates technology, services, and clinical intelligence to orchestrate personalized care experiences across virtual primary care, urgent care, behavioral health, chronic condition management, and specialized digital programs.

Backed by 20 years of technology-enabled care innovation, more than 90 million covered lives, and over 38.7 million virtual visits, Amwell continues to help health plans and healthcare organizations modernize digital care delivery at scale.

“As healthcare becomes more digital, it risks becoming more fragmented. Health plans need more than point solutions. They need enterprise infrastructure, clinical integration, and an open platform that brings partners and programs together. Our vision at Amwell is that technology creates value when it improves access, engagement, quality, and efficiency, and produces measurable clinical and business outcomes. We’re honored by this recognition from Frost & Sullivan,” said Dan Zamansky, Chief Product and Technology Officer at Amwell.

Amwell’s enterprise scale includes supporting the digital transformation of the Defense Health Agency’s Military Health System, serving approximately 9.6 million beneficiaries. The company’s commitment to measurable outcomes is also reflected in a landmark National Institute of Mental Health (NIMH)-funded study, published in Nature Human Behaviour and among the largest studies of its kind. The study found that students offered SilverCloud® by Amwell® engaged in mental healthcare at more than double the rate of traditional care, experienced lower rates of mental health disorders, and generated an estimated $1.18 million in avoided costs for the study population.

The company further differentiates its platform through intelligent orchestration and navigation, helping guide members to appropriate programs while giving clinicians visibility across care plans. Amwell also evaluates integrated third-party programs for clinical effectiveness, scalability, and enterprise readiness.

Frost & Sullivan commends Amwell for setting a high standard in competitive strategy, execution, and technological innovation. The company’s unified approach to digital care is helping reduce fragmentation, improve access, strengthen operational efficiency, and support more equitable and sustainable healthcare delivery.

Each year, Frost & Sullivan presents the Technology Innovation Leadership Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The recognition identifies forward-thinking organizations that are reshaping their industries through innovation and growth excellence.

Frost & Sullivan Best Practices Recognition

Frost & Sullivan’s Best Practices Recognitions honor companies across regional and global markets that exhibit exceptional achievement and consistent excellence in areas such as leadership, technological innovation, customer experience, and strategic product development. Each recognition is the result of a rigorous analytical process in which Frost & Sullivan industry experts benchmark performance through comprehensive interviews, deep-dive analysis, and extensive secondary research. The goal is to identify true best-in-class organizations that are driving transformative growth and setting new industry standards.
Contact us: Start the discussion.

Contact:
Ashley Shreve
E: ashley.weinkauf@frost.com 

View original content:https://www.prnewswire.com/news-releases/amwell-receives-frost–sullivans-2026-united-states-technology-innovation-leadership-recognition-for-technology-enabled-care-platforms-302870492.html

SOURCE Frost & Sullivan

Continue Reading

Technology

Midea Brings “Simply ideal” to Life at IFA 2026

Published

3 hours ago

on

September 4, 2026

By

BERLIN, Sept. 4, 2026 /PRNewswire/ — At IFA 2026, Midea brings its “Simply ideal” vision to life through the latest innovations, designed to bring greater intelligence, comfort, efficiency and ease to the home.

The exhibition also highlights Midea’s new five-year partnership with FC Barcelona.

The Midea Suites: Ways to Master the Home

The new SMART MASTER showcases Midea’s AI-powered home ecosystem. The AI Agent enables more natural, intuitive interaction with appliances across daily household scenarios. Midea Robot brings AI into the physical world through cooking, cleaning, laundry, care and whole-home control.

At IFA 2026, Midea unveiled its new AI voice-controlled air conditioner. Cliff Liang, General Manager of Enterprise Commercial for the China Region at Microsoft, joined the Midea event and shared Microsoft’s perspective on the next phase of AI.

AI ECOMASTER coordinates appliances and connected systems through intelligent power management. It learns household routines and adapts to changing needs for greater flexibility and comfort.

For homes where every inch counts, SPACE MASTER delivers more usable capacity within the same external dimensions, as demonstrated by the refrigerator’s expanded storage.

Alongside the MASTER Suites, the BUILT-IN Series includes the Milanese-inspired Ispira Series, combining cohesive design with intelligent functionality for an integrated cooking experience.

The Midea Scenarios: Innovation for Everyday Living

Comfort begins with the air around us. Midea’s R290 Series responds to growing demand for efficient cooling. It combines advanced compressor and safety-sealing technologies with ultra-low-GWP R290 refrigerant, delivering around 10% higher energy efficiency. Residential applications include H-Pack and PortaSplit, with PortaSplit set to adopt R290 in 2027.

In the kitchen, technology simplifies daily routines, from food storage and cooking to after-meal care. The Visionary Series refrigerators make food easier to see and access through GlassVision, hands-free lighting and clear, even illumination.

The InfiniteFit Series hobs feature an ultra-slim design for seamless integration into European kitchens, while OmniFlex enables flexible cookware placement. The PizzaPro built-in oven combines rapid heating with an 81L cavity, balancing speed with capacity.

After the meal, the Tri-GreenApex System brings washing, drying and storage together while using around 50% less energy than required for Europe’s highest A rating.

Laundry brings its own everyday needs. Midea’s family laundry room concept combines multi-drum solutions for different garment-care needs, allowing separate loads to run at the same time. The OMNI SERIES offers flexible combinations to suit different household routines.

Tobin Richardson, President and CEO of the Connectivity Standards Alliance, introduced Matter at Midea’s booth, highlighting its open, secure, interoperable framework and Midea’s role in advancing smart appliance connectivity.

Partnership and Brand Portfolio

At IFA 2026, Midea celebrated its partnership through an immersive FC Barcelona experience at its booth. FC Barcelona legend Carles Puyol made a special appearance, sharing insights from his career on leadership, teamwork and the pursuit of excellence. His presence reflected Midea and FC Barcelona’s shared commitment to world-class performance.

As part of Midea Group’s multi-brand portfolio, TEKA presents its latest innovations under the “Meaningful Experiences Through Technology” concept, including its new coffee machine range, the In-Line Series and Laundry Care solutions, bringing European design and functionality to modern living.

About Midea and Midea Group

Midea is one of over 10 brands within the Smart Home Business of Midea Group.

Founded in 1968, Midea Group is a leading global technology company and one of the world’s largest home appliance manufacturers. As a Fortune Global 500 enterprise, it ranked No. 231 in 2026. The Group has streamlined its core operations into seven high-growth business pillars to drive future growth: Smart Home, Industrial Technologies, Building Technologies, KUKA, New Energy, Midea Healthcare, and ANNTO Logistics.

www.midea-group.com

www.midea.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/midea-brings-simply-ideal-to-life-at-ifa-2026-302870435.html

SOURCE Midea Group

Continue Reading

Trending